Compliance Update

These 3 policy moves are likely to change healthcare for older people

Month after month, Patricia Hunter and other members of the Nursing Home Reform Coalition logged onto video calls with congressional representatives, seeking support for a proposed federal rule setting minimum staff levels for nursing homes. Finally, after decades of advocacy, the Biden administration in 2023 tackled the problem of perennial understaffing of long-term care facilities. Officials...

read more

Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescribing Controlled Substances

On December 31, 2025, the Drug Enforcement Administration (DEA), jointly with the U.S. Department of Health and Human Services (HHS), published a temporary rule that extends the COVID-era “telemedicine flexibilities” for prescribing Schedule II–V controlled substances through December 31, 2026 (the fourth temporary extension). The rule is effective January 1, 2026 through December 31, 2026, and...

read more

How delays and bankruptcy let a nursing home chain avoid paying settlements for injuries and deaths

Nancy Hunt arrived at an emergency room from a Genesis HealthCare nursing home in Pennsylvania in such dreadful shape, including maggots infesting her gangrened foot, that the hospital called an elder abuse hotline and then the police, her son alleged in a lawsuit. Hunt died five days later. Her death certificate said the foot injury was a “significant” factor. Genesis denied wrongdoing but...

read more

The FDA memo that shakes the world

Over the last November weekend of 2025, a memo circulated throughout the Federal Food and Drug Administration that might well trigger the entire unraveling of the US vaccine program with a focus on the mandated COVID shot in particular. The author is Dr. Vinay Prasad, who was a moderate critic during the COVID but has become ferocious since his appointment as the head of the Center for Biologics...

read more

FDA recall of blood pressure pills due to cancer-causing contaminant may point to higher safety risks in older generic drugs

Nitrosamines are by-products of many common chemical reactions. FatCamera/iStock via Getty Images Plus ~~~~~ A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it contains elevated levels of cancer-causing chemicals called nitrosamines. The recall, which Teva announced on Oct. 7, 2025, affects more than...

read more

Smart defense for fraud allegations

An effective defense for fraud allegations begins with proactive compliance controls tailored to healthcare operations. Federal and state authorities increasingly scrutinize billing patterns, documentation and financial relationships under the False Claims Act, 31 U.S.C. § 3729 et seq., the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b, and related regulations. As a healthcare executive, you must...

read more